Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$136,811,765
-$3,096,690 QoQ
Shares Held
1,064,683
-8.5% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#178
of 3,768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. MRK ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,811,765 | 1,064,683 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $139,908,455 | 1,163,093 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $136,419,169 | 1,296,021 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $106,322,102 | 1,266,795 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,725,659 | 1,247,166 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $129,157,637 | 1,438,922 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $192,861,973 | 1,938,701 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $238,981,227 | 2,104,449 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $260,173,869 | 2,101,566 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $281,525,615 | 2,133,578 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $237,985,317 | 2,182,951 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $245,310,596 | 2,382,813 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $277,791,614 | 2,407,415 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $261,029,458 | 2,453,515 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $274,801,069 | 2,476,801 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $262,388,863 | 3,046,782 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $287,097,336 | 3,149,033 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $246,213,669 | 3,000,776 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $224,511,285 | 2,929,427 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $228,688,392 | 3,044,713 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $226,015,562 | 2,906,205 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $201,986,777 | 2,620,141 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $190,294,198 | 2,326,336 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $194,347,293 | 2,342,944 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $159,159,050 | 2,058,179 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $149,453,501 | 1,942,469 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||